Loading...
01/10 19:55
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong financial performance with a 15% revenue increase and improved cash flow. Positive free cash flow and a strong cash position, along with a focus on product development, contribute to a positive outlook. Despite concerns about economic factors, management's resilience and strategic focus on growth and shareholder value are reassuring. The Q&A reveals no significant risks or uncertainties, and management's opportunistic share repurchase plan suggests confidence in future performance. Given the company's small-cap status, a positive stock price movement is expected.
Revenue $115.9 million, an increase of 15% year-over-year.
Average Healthcare Services Clients 4,411, an increase of 346 from the prior year.
Total Revenue per Average Healthcare Services Client $26,283, up 6% year-over-year.
Adjusted EBITDA $20.8 million, an increase of 16.7% year-over-year with an adjusted EBITDA margin of 18%.
Cash and Cash Equivalents $90.9 million, compared to $84.2 million in the prior quarter.
Operating Cash Flow $14.9 million, up $15.6 million year-over-year.
Free Cash Flow $7.5 million, up $13.7 million year-over-year.
New Products: Products such as appointment readiness, post script engagement and enhanced bill pay were developed and introduced with long term value in mind and are already showing measurable impact across the network.
AI Integration: AI is being integrated across all aspects of our organization and our current and future products.
Client Growth: We ended the quarter with average healthcare services clients of 4,411, an increase of 70 from the prior quarter and 346 from the prior year.
Revenue Growth: Revenue was $115.9 million, an increase of 15% year-over-year.
Adjusted EBITDA: Adjusted EBITDA was $20.8 million, an increase of 16.7% year-over-year with an adjusted EBITDA margin of 18%.
Cash Flow: Operating cash flow remained positive at $14.9 million, up $15.6 million year-over-year. Free cash flow remains positive at $7.5 million in the quarter, up $13.7 million year-over-year.
Financial Outlook: We are maintaining our revenue outlook for the fiscal year 2026 at a range of $472 million to $482 million and updating our adjusted EBITDA outlook for fiscal year 2026 to a range of $85 million to $90 million.
Competitive Pressures: The company faces competitive pressures in the healthcare technology market, which may impact its growth and market share.
Regulatory Issues: Potential regulatory changes in the healthcare sector could pose risks to the company's operations and compliance.
Supply Chain Challenges: Supply chain disruptions could affect the availability of necessary resources and technology for product development.
Economic Factors: Economic downturns or fluctuations may impact healthcare spending and, consequently, the company's revenue.
Forward-Looking Statements: The company acknowledges that forward-looking statements are subject to various risks and uncertainties that could lead to actual results differing materially from expectations.
Product Development: Focus on delivering valuable and scalable products such as appointment readiness, post script engagement, and enhanced bill pay.
AI Integration: Integration of AI across all aspects of the organization and products.
Network Growth: Positioned for growth through product-led initiatives.
Capital Allocation: Strong balance sheet and growing free cash flow to allocate capital for long-term shareholder value.
Revenue Outlook: Maintaining revenue outlook for fiscal year 2026 at a range of $472 million to $482 million.
Adjusted EBITDA Outlook: Updated adjusted EBITDA outlook for fiscal year 2026 to a range of $85 million to $90 million, up from previous range of $78 million to $88 million.
AHSCs Projection: Reiterating outlook on average healthcare services clients (AHSCs) to reach approximately 4,500 in fiscal 2026.
Revenue per AHSC: Total revenue per AHSC expected to increase in fiscal 2026 compared to fiscal 2025.
Free Cash Flow: Free cash flow remains positive at $7.5 million in the quarter, up $13.7 million year-over-year.
Cash Position: We ended the quarter with $90.9 million in cash and cash equivalents.
Shareholder Value: We will remain opportunistic and flexible in our approach to deploying cash to profitable growth and value enhancing opportunities as they arise.
The earnings call presents strong financial metrics, including consecutive positive net income and increased cash flow, which are positive indicators. The Q&A session highlights a cautious but optimistic outlook, with plans for strategic investments and growth. While some management responses lack clarity, the overall sentiment is positive due to strong cash flow, margin expansion, and growth potential from acquisitions. The market cap suggests a moderate reaction, leading to a positive stock price movement prediction.
The earnings call summary highlights strong financial metrics, optimistic guidance, and strategic acquisitions like AccessOne, which align with market expansion and product development goals. The Q&A session revealed analyst confidence in AI integration and new product offerings, despite some uncertainty regarding specific revenue details. The company's market cap suggests a moderate reaction, leading to a positive stock price movement prediction of 2% to 8% over the next two weeks.
The earnings call indicates strong financial performance with a 15% revenue increase and improved cash flow. Positive free cash flow and a strong cash position, along with a focus on product development, contribute to a positive outlook. Despite concerns about economic factors, management's resilience and strategic focus on growth and shareholder value are reassuring. The Q&A reveals no significant risks or uncertainties, and management's opportunistic share repurchase plan suggests confidence in future performance. Given the company's small-cap status, a positive stock price movement is expected.
The earnings call revealed strong financial performance, including a 15% revenue increase and solid EBITDA growth. The share repurchase plan indicates confidence in stock value, likely boosting investor sentiment. While regulatory risks exist, management's focus on product value and resilience in client engagement are reassuring. The positive financial metrics and strategic initiatives outweigh the hesitancy in client decision-making, suggesting a positive stock price movement. Given the market cap of $1.2 billion, the reaction is expected to be in the positive range of 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
